Free tool
FAERS Monitor: Clozaril
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 019758 or its brand name (Clozaril, Clozapine). Reports on generic versions are filed under their own applications.
Reports
126,443
Serious
119,771
95% of reports
Hospitalization
55,395
Death reported
22,748
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- neutropenia18,972
- hospitalisation12,562
- death12,371
- schizophrenia4,755
- white blood cell count increased4,541
- white blood cell count decreased4,532
- neutrophil count increased4,203
- drug ineffective4,034
- malaise3,900
- off label use3,854
- treatment noncompliance3,399
- pneumonia3,316
- neutrophil count decreased3,217
- drug interaction3,202
- haemoglobin decreased3,193
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,706 |
| 2005 | 1,588 |
| 2006 | 2,443 |
| 2007 | 924 |
| 2008 | 932 |
| 2009 | 1,994 |
| 2010 | 2,874 |
| 2011 | 5,628 |
| 2012 | 4,175 |
| 2013 | 3,012 |
| 2014 | 3,388 |
| 2015 | 4,170 |
| 2016 | 4,537 |
| 2017 | 7,274 |
| 2018 | 6,822 |
| 2019 | 7,450 |
| 2020 | 8,080 |
| 2021 | 7,359 |
| 2022 | 13,918 |
| 2023 | 13,134 |
| 2024 | 11,704 |
| 2025 | 8,282 |
| 2026 | 5,039 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,927,716 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| neutrophil count increasedSignal | 4,203 | 115.1 | 110.7 | 280,407 |
| schizophreniaSignal | 4,755 | 106.2 | 102.5 | 302,017 |
| neutropeniaSignal | 18,972 | 26.8 | 26.4 | 408,274 |
| white blood cell count increasedSignal | 4,541 | 22.2 | 21.5 | 81,183 |
| hospitalisationSignal | 12,562 | 14.7 | 14.5 | 148,598 |
| neutrophil count decreasedSignal | 3,217 | 14.2 | 13.7 | 36,324 |
| treatment noncomplianceSignal | 3,399 | 11.0 | 10.6 | 28,898 |
| white blood cell count decreasedSignal | 4,532 | 7.2 | 7.0 | 23,360 |
| haemoglobin decreasedSignal | 3,193 | 5.3 | 5.1 | 10,861 |
| drug interactionSignal | 3,202 | 3.4 | 3.3 | 5,370 |
| deathSignal | 12,371 | 2.4 | 2.4 | 10,475 |
| pneumonia | 3,316 | 1.7 | 1.7 | 984 |
| malaise | 3,900 | 1.5 | 1.4 | 622 |
| off label use | 3,854 | 0.7 | 0.7 | 396 |
| drug ineffective | 4,034 | 0.5 | 0.5 | 2,048 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.